| 663 |
Centers for Disease Control and Prevention |
Html |
en |
Bidis and Kreteks - Smoking & Tobacco Use |
Tobacco Industry and Products Fact Sheets. |
| Mortality Weekly Report | 0.736921 |
| reduced oxygen absorption | 0.46092 |
| nicotine addiction | 0.411423 |
| Tobacco Control Act | 0.611152 |
| conventional cigarettes | 0.418918 |
| lung cancer | 0.437099 |
| Disease Control | 0.52913 |
| oral cancer | 0.475271 |
| Yusuf S. Risk | 0.466429 |
| World Health Organization | 0.621106 |
| Clove Cigarette Smoking | 0.537694 |
| Occupational Lung Diseases | 0.462932 |
| Risk Factors | 0.459423 |
| High School Students—United | 0.725188 |
| carbon monoxide | 0.489706 |
| bidi smoking | 0.968962 |
| Bidi Cigarettes | 0.670044 |
| long-term health effects | 0.643066 |
| Nov | 0.624469 |
| Southeast Asian countries | 0.48994 |
| International Journal | 0.447961 |
| combustible tobacco product | 0.517574 |
| Family Smoking Prevention | 0.536764 |
| U.S. middle school | 0.485032 |
|
| Fukui T. Bidi | 0.800783 |
| acute lung injury | 0.49234 |
| S. Bidi Smoking | 0.684593 |
| Bidi Cigarette | 0.568238 |
| United States.1,3,5,6 | 0.410967 |
| hand-rolled cigarettes | 0.426767 |
| flavored cigarettes | 0.412101 |
| Regular kretek smokers | 0.474755 |
| School Students—United States | 0.723091 |
| Tobacco Research. | 0.423906 |
| Carbon Monoxide Yields | 0.459948 |
| high school students | 0.481784 |
| kretek smoking | 0.511201 |
| middle school males | 0.485466 |
| lung problems | 0.415878 |
| T. Bidi Smoking | 0.835199 |
| bidis | 0.515884 |
| relative standard error | 0.459828 |
| stomach cancer | 0.412786 |
| low prevalence | 0.490352 |
| research studies | 0.48493 |
| coronary heart disease | 0.477084 |
| adverse health conditions | 0.496028 |
| abnormal lung function | 0.489677 |
|
CLICK HERE |
| 992 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: A Cluster of LymphocyticChoriomeningitis Virus Infections Transmitted Through OrganTransplantation - Iowa, 2013 |
Ilana J. Schafer, DVM1, Rachel Miller, MD2, Ute Ströher, PhD3, Barbara Knust, DVM3, Stuart T. Nichol, PhD3, Pierre E. |
| CDC | 0.757274 |
| mental status | 0.719175 |
| mild memory deficits | 0.814435 |
| public health practitioners | 0.795062 |
| Human Services | 0.785501 |
| immunoglobulin M. Patient | 0.859371 |
| MMWR HTML versions | 0.793484 |
| U.S. Department | 0.782906 |
| rodent exposure | 0.819648 |
| Organ Sharing | 0.816741 |
| organ transplantation | 0.89541 |
| oral ribavirin | 0.881817 |
| electronic PDF version | 0.795955 |
| prompt treatment initiation | 0.798038 |
| lymphocytic choriomeningitis virus | 0.832608 |
| LCMV-infected organ recipients | 0.933902 |
| large intracerebral hemorrhage | 0.844404 |
| early posttransplant period | 0.796513 |
| allograft failure | 0.712583 |
| Contact GPO | 0.719617 |
| organ transplant recipients | 0.989377 |
| transcription–polymerase chain reaction | 0.810411 |
| nontransplanted donor organs | 0.844486 |
| LCMV infections | 0.821141 |
|
| respiratory compromise | 0.716239 |
| original paper copy | 0.788648 |
| causative agent | 0.719132 |
| previous cornea recipients | 0.867208 |
| right kidney | 0.716729 |
| Diagnostic testing | 0.719774 |
| ill recipients | 0.856017 |
| original MMWR paper | 0.8013 |
| U.S. Government Printing | 0.796838 |
| blood samples | 0.716659 |
| aortic endothelial cells | 0.813912 |
| multiple recipients | 0.763598 |
| influenza-like illness | 0.722587 |
| critical condition | 0.718147 |
| United Network | 0.729508 |
| intravenous ribavirin treatment | 0.916692 |
| common organ donor | 0.968628 |
| life-threatening disease | 0.726203 |
| intravenous immunoglobulin | 0.744662 |
| rodent-borne virus | 0.721405 |
| organ donors | 0.777923 |
| organ transplant-associated cluster | 0.882185 |
| occasional aseptic meningitis | 0.834182 |
| intracranial hemorrhage | 0.725978 |
|
CLICK HERE |
| 5752 |
Centers for Disease Control and Prevention |
Html |
en |
Methyl formate - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6898 |
Centers for Disease Control and Prevention |
Html |
en |
Rabies Risk Assessment of Exposures to a Bat on a Commercial Airliner - United States, August 2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| risk assessment | 0.734352 |
| bat saliva | 0.455304 |
| commercial airliner | 0.500532 |
| early morning flight | 0.469719 |
| rabies virus transmission | 0.550916 |
| bat | 0.688891 |
| Public Health Madison | 0.521852 |
| Zoonotic Infectious Diseases | 0.512782 |
| risk assessment tool | 0.590371 |
| flight crew | 0.582539 |
| potential bat contact | 0.540223 |
| passengers | 0.798755 |
| rabies diagnostic testing | 0.539829 |
| public health precaution | 0.443801 |
| public health officials | 0.646357 |
| rabies virus variants | 0.640596 |
| rabies transmission | 0.539534 |
| bat sightings | 0.500149 |
| airport | 0.473698 |
| Airport Environmental Assessment | 0.456851 |
| environmental assessment | 0.475763 |
| Dane County | 0.456612 |
| previous bat sightings | 0.495286 |
| rabies status | 0.520158 |
|
| commercial airline flight | 0.454758 |
| rabies virus | 0.91107 |
| flight | 0.635442 |
| airline passengers increases | 0.525045 |
| United States | 0.524564 |
| bat capture | 0.442359 |
| human rabies | 0.645787 |
| bats | 0.528067 |
| unidentified passengers | 0.487164 |
| Immunization Practices | 0.486623 |
| Advisory Committee | 0.486251 |
| risk-assessed passengers | 0.461206 |
| rabies risk assessment | 0.629931 |
| maintenance crew members | 0.456115 |
| flight crew members | 0.519016 |
| public health | 0.967835 |
| human rabies cases | 0.555506 |
| separate risk assessment | 0.442692 |
| aircraft cabin | 0.476689 |
| flight attendant | 0.460263 |
| bat droppings | 0.448496 |
| rabies vaccination history | 0.568233 |
| ground crew members | 0.95456 |
| postexposure rabies | 0.549147 |
|
CLICK HERE |
| 7684 |
Centers for Disease Control and Prevention |
Html |
en |
Collegiate Leaders in Environmental Health (CLEH) - 2011 Intern Profiles |
CDC Collegiate Leaders in Environmental Health - 2011 Intern Profiles |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7796 |
Centers for Disease Control and Prevention |
Html |
en |
Hepatitis B - Health Communication |
Hepatitis B - Gateway to Health Communication - CDC |
| new infections | 0.492527 |
| doctor orders | 0.48298 |
| infected sex partner | 0.612825 |
| three-dose series | 0.485645 |
| sex partners | 0.540791 |
| United States | 0.581689 |
| complete physical exam | 0.550453 |
| hepatitis B virus | 0.624218 |
| health care provider | 0.56318 |
| blood tests | 0.560052 |
| HBV-related liver cancer | 0.580351 |
| needle sticks | 0.491787 |
| local health department | 0.54505 |
| possible antiviral therapy | 0.552028 |
| medical evaluation | 0.483317 |
| HBV). | 0.614825 |
| direct contact | 0.495329 |
| popular captain | 0.482908 |
| illegal drugs | 0.490717 |
| chronic liver disease | 0.606108 |
| suburban high school | 0.551905 |
| Jack | 0.503703 |
| increased risk | 0.488077 |
| sharps exposures | 0.496607 |
|
| stomach pains | 0.487925 |
| acute hepatitis B. | 0.647246 |
| common side effect | 0.486295 |
| football team | 0.485436 |
| Yes. Hepatitis | 0.600309 |
| vaccine series | 0.524381 |
| body fluids | 0.491363 |
| joints ache | 0.486721 |
| hepatitis | 0.913754 |
| people | 0.48676 |
| infected person | 0.620997 |
| chronic HBV infection | 0.828108 |
| doctor | 0.502214 |
| sexually transmitted diseases | 0.550854 |
| chronic hepatitis | 0.698157 |
| infected mother | 0.562329 |
| effective vaccine | 0.529429 |
| chronic infection | 0.528149 |
| HBV infection | 0.885622 |
| young adults | 0.488755 |
| hepatitis b vaccine | 0.783222 |
| liver cancer | 0.786581 |
| hepatitis panel | 0.580762 |
|
CLICK HERE |
| 8810 |
Centers for Disease Control and Prevention |
Html |
en |
Naegleria fowleri - Images of Naegleria fowleri |
Information for health professionals about Naegleria fowleri. Education and information about the brain eating ameba Naegleria fowleri that causes encephalitis and death including frequently asked questions, biology, sources of infection, diagnosis, treatment, prevention and control, and other publications and pertinent information for the public and medical professionals. |
| large numbers | 0.352042 |
| arrows | 0.310526 |
| section | 0.329492 |
| videos | 0.310923 |
| photos | 0.310137 |
| characteristic nuclear morphology | 0.400604 |
| shipping instructions | 0.364528 |
| large cluster | 0.350598 |
| CDC Emergency Operations | 0.41789 |
| real-time | 0.3108 |
| cerebral portion | 0.414138 |
| wet mount | 0.357582 |
| contact | 0.311015 |
| specimen collection guidance | 0.416747 |
| magnification | 0.43167 |
| phase contrast microscopy | 0.40793 |
| lymphocytes | 0.316101 |
| Higher magnification | 0.396906 |
| Extensive hemorrhage | 0.414053 |
| eosin | 0.318795 |
| Focal hemorrhage | 0.419633 |
| viewers | 0.310654 |
| laboratory diagnosis | 0.419395 |
| photographs | 0.310917 |
| Naegleria fowleri trophozoites | 0.96664 |
|
| exciter filter | 0.355814 |
| large clusters | 0.354855 |
| 24/7 | 0.311057 |
| increased speed | 0.359511 |
| primary amebic meningoencephalitis | 0.418066 |
| Inset | 0.313369 |
| capillaries | 0.313385 |
| PAM patient | 0.467978 |
| treatment recommendations | 0.362499 |
| microscope | 0.323216 |
| frontal cortex | 0.499044 |
| Clinicians | 0.311632 |
| variety | 0.310119 |
| CSF | 0.338105 |
| cysts | 0.328578 |
| brain tissue architecture | 0.402336 |
| Naegleria fowleri trophozoite | 0.645375 |
| polymorphonuclear leukocytes | 0.362375 |
| Center | 0.310998 |
| fluorescent antibody | 0.358053 |
| nucleus | 0.311602 |
| necrosis | 0.351242 |
| diagnostic assistance | 0.364662 |
| anti-Naegleria fowleri antibody | 0.52538 |
|
CLICK HERE |
| 9669 |
Centers for Disease Control and Prevention |
Html |
en |
Veterinary Safety and Health - Other hazards |
null |
| 2004-100D (DVD) | 0.376194 |
| Publications No. | 0.263463 |
| Español | 0.22413 |
| email address | 0.393602 |
| NIOSH The Effects | 0.610531 |
| different file formats | 0.370311 |
| Health Issues | 0.263229 |
| NIOSH Publication No. | 0.957047 |
| animal owners | 0.278399 |
|
| DHHS | 0.235309 |
| AVMA Emergency contact | 0.457198 |
| Workplace Hazards | 0.332927 |
| NIOSH Exposure | 0.595051 |
| Occupational Hazards | 0.4552 |
| Female Reproductive Health | 0.402502 |
| Workplace Violence Prevention | 0.435498 |
| Research Needs | 0.253523 |
|
CLICK HERE |
| 10060 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH Program Portfolio : Personal Protective Technology : Key Partners and Stakeholders |
The Mission of the PPT Program is to prevent work-related injury, illness, and death by advancing the state of knowledge and application of personal protective technologies (PPT). |
| technology developers | 0.612875 |
| PPT Programs | 0.725604 |
| research priorities | 0.643272 |
| section | 0.532615 |
| sites | 0.532564 |
| expertise | 0.520077 |
| experience | 0.520055 |
| PPT Program execution | 0.846226 |
| official endorsement | 0.717445 |
| NIOSH research dollars | 0.811226 |
| concern | 0.523249 |
| core competencies augment | 0.723202 |
| research team | 0.628562 |
| in-kind contributions | 0.635827 |
| surveillance activities | 0.612094 |
| safety | 0.521698 |
| inherent knowledge | 0.637908 |
| communication | 0.519939 |
| circumstances | 0.521349 |
| following links | 0.699841 |
| PPE needs | 0.629782 |
| protective strategies | 0.614461 |
| Disclaimer | 0.559452 |
| analysis | 0.519976 |
| key stakeholders | 0.637076 |
|
| NIOSH Program | 0.724514 |
| input | 0.549842 |
| stakeholder groups | 0.642994 |
| programmatic accomplishments | 0.621268 |
| targets | 0.52113 |
| content | 0.532374 |
| ultimate success | 0.619272 |
| key partners | 0.606873 |
| NIOSH policy | 0.747323 |
| PPT Program | 0.976006 |
| partnerships | 0.552263 |
| statement | 0.532311 |
| definition | 0.541177 |
| customers | 0.521814 |
| workers | 0.521682 |
| entire process | 0.609025 |
| capabilities | 0.536541 |
| CDC/NOSH | 0.532526 |
| PPT Program research | 0.836638 |
| PPT Program model | 0.840932 |
| health | 0.521713 |
| Collaborative research | 0.62798 |
| jointly developed program | 0.714378 |
| user communities | 0.617743 |
|
CLICK HERE |
| 11966 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH-Approved N100 Particulate Filtering Facepiece Respirators - Suppliers List |
This page contains a suppliers list of NIOSH-Approved N100 Particulate Filtering Facepiece Respirators. |
| PDF version | 0.711788 |
| facepiece respirator | 0.852905 |
| airborne particles | 0.845824 |
| CDC/NIOSH | 0.553908 |
| N100 | 0.464889 |
| procedure | 0.482707 |
| Disclaimer | 0.5265 |
|
| official endorsement | 0.84325 |
| content | 0.496522 |
| NIOSH policy | 0.955076 |
| oil | 0.463497 |
| statement | 0.495902 |
| websites | 0.498321 |
| links | 0.457956 |
|
CLICK HERE |